Cargando…
Identification of L-asparaginases from Streptomyces strains with competitive activity and immunogenic profiles: a bioinformatic approach
The enzyme L-asparaginase from Escherichia coli is a therapeutic enzyme that has been a cornerstone in the clinical treatment of acute lymphoblastic leukemia for the last decades. However, treatment effectiveness is limited by the highly immunogenic nature of the protein and its cross-reactivity tow...
Autores principales: | González-Torres, Iván, Perez-Rueda, Ernesto, Evangelista-Martínez, Zahaed, Zárate-Romero, Andrés, Moreno-Enríquez, Angélica, Huerta-Saquero, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668207/ https://www.ncbi.nlm.nih.gov/pubmed/33240625 http://dx.doi.org/10.7717/peerj.10276 |
Ejemplares similares
-
Rhizobium etli asparaginase II: An alternative for acute lymphoblastic leukemia (ALL) treatment
por: Huerta-Saquero, Alejandro, et al.
Publicado: (2013) -
Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance
por: Villanueva-Flores, Francisca, et al.
Publicado: (2021) -
Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment
por: Díaz-Barriga, Cristina, et al.
Publicado: (2021) -
A Novel Formulation of Asparaginase Encapsulated into Virus-like Particles of Brome Mosaic Virus: In Vitro and In Vivo Evidence
por: Villanueva-Flores, Francisca, et al.
Publicado: (2023) -
Purification, characterization and immunogenicity assessment of glutaminase free L-asparaginase from Streptomyces brollosae NEAE-115
por: El-Naggar, Noura El-Ahmady, et al.
Publicado: (2018)